Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trials

Fengcai Zhu, Ningshao Xia, Zehong Huang et al.|The Lancet Respiratory Medicine|2022

Cited by 140